Table 19. Number of patients receiving medication.

Medication	Initial PSG	Final PSG
Betablockers	284 (40%)	302 (42%)
ACE-inhibitors	235 (33%)	255 (36%)
Angiotensin-receptor-blockers	114 (16%)	135 (19%)
Central antihypertensives	35 (5%)	37 (5%)
Antidepressants	147 (21%)	158 (22%)
Neuroleptics	33 (5%)	32 (5%)
Tranquilizer	22 (3%)	25 (4%)
Opioids	13 (2%)	23 (3%)
Antiparkinson therapy	20 (3%)	27 (4%)
Thyroid replacement therapy	124 (17%)	118 (17%)
PD5-Inhibitors	2 (0%)	3 (0%)
Endothelin-receptor-antagonists	5 (1%)	7 (1%)
Systemic Glucocorticoids	2 (0%)	4 (1%)